VXB-241

RSV-HMPV bivalent vaccine · Vicebio Australia Proprietary Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VXB-241, covering 2025-10-01 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults [Phase 1]